Minas Gerais Federal University is developing new Covid-19 vaccine

Unlike Butantan or Biomanguinhos, which import technology from abroad to produce vaccines in Brazil, the University's technical center is building a process from start to finish.

RIO DE JANEIRO, BRAZIL - Provided everything goes as planned and the required investments are made, Brazil will have a domestic vaccine against the novel coronavirus (Covid-19) in 2022. The first national immunizer against Covid-19 is being developed by the Center of Technology in Vaccines (CT-Vacinas) of the Federal University of Minas Gerais (UFMG).

The partnership agreement signed on February 4th between UFMG, the Minas Gerais state government and the Ministry of Science, Technology and Innovation (MCTI) may expedite vaccine production in the state, said professor Ana Paula Fernandes, one of the coordinators of CT-Vacinas.

She added . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?